Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Jennifer Leigh Lund

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1108-0689; OpenAlex author ID A5030530617. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Effect of surgery versus chemotherapy in pancreatic cancer patients: a target trial emulation. Co-author DOI 10.1093/jnci/djae024↗
  2. Statins and pancreatic cancer risk in patients with chronic pancreatitis: A Danish nationwide population-based cohort study. First author DOI 10.1002/ijc.32264↗
  3. Acute pancreatitis as an early marker of pancreatic cancer and cancer stage, treatment, and prognosis. Co-author DOI 10.1016/j.canep.2019.101647↗
  4. Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pan… Last author DOI 10.1634/theoncologist.2019-0570↗
  5. Author's Reply to: "Design flaws in statins and pancreatic cancer research" (IJC-19-0941). First author DOI 10.1002/ijc.32349↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Frank Viborg Mortensen · 4 shared papers, 2019–2024 · strength 0.66
  2. Deirdre P Cronin-Fenton · 4 shared papers, 2019–2024 · strength 0.66
  3. Jakob Kirkegård · 4 shared papers, 2019–2024 · strength 0.66
  4. Charles E. Gaber · 2 shared papers, 2020–2024 · strength 0.36
  5. Uffe Heide‐Jørgensen · 2 shared papers, 2020–2024 · strength 0.36
  6. Claus Wilki Fristrup · 1 shared paper, 2024 · strength 0.24
  7. Hanna Kelly Sanoff · 1 shared paper, 2020 · strength 0.13
  8. Robert W. Corty · 1 shared paper, 2020 · strength 0.13
  9. Morten Bækbo Ladekarl · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.